PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 172 filers reported holding PRECIGEN INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $227 | +15.8% | 159,848 | -6.2% | 0.00% | – |
| Q2 2023 | $196 | -3.0% | 170,355 | -10.6% | 0.00% | – |
| Q1 2023 | $202 | -25.7% | 190,455 | +6.6% | 0.00% | – |
| Q4 2022 | $272 | -99.9% | 178,734 | 0.0% | 0.00% | – |
| Q3 2022 | $379,000 | +156.1% | 178,734 | +61.6% | 0.00% | – |
| Q2 2022 | $148,000 | -5.7% | 110,624 | +49.0% | 0.00% | – |
| Q1 2022 | $157,000 | -34.9% | 74,266 | +14.5% | 0.00% | – |
| Q4 2021 | $241,000 | +131.7% | 64,866 | +212.4% | 0.00% | – |
| Q3 2021 | $104,000 | -23.0% | 20,766 | 0.0% | 0.00% | – |
| Q2 2021 | $135,000 | +12.5% | 20,766 | +19.2% | 0.00% | – |
| Q1 2021 | $120,000 | -57.7% | 17,415 | -37.5% | 0.00% | – |
| Q4 2020 | $284,000 | +55.2% | 27,879 | -46.6% | 0.00% | – |
| Q3 2020 | $183,000 | -29.6% | 52,179 | 0.0% | 0.00% | – |
| Q2 2020 | $260,000 | +30.0% | 52,179 | -11.4% | 0.00% | – |
| Q1 2020 | $200,000 | – | 58,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |